We recently compiled a list of the Last Week’s Top 10 Stocks Post Double-Digit Gains. In this article, we are going to take a ...
We recently published a list of the Top 10 AI Stocks Buzzing on Latest News. In this article, we are going to take a look at ...
MarketBeat on MSN1d
Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite?NVIDIA's continued investment in Recursion Pharmaceuticals strengthens the view that Recursion is a favored investment within ...
In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against other best performing healthcare stocks so far in 2025. Despite the ongoing craze ...
In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against the other stocks. The stock market may have registered losses on Friday ...
We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...
Today, Altitude Lab announced that its incubating startups have collectively raised $154 million in early-stage funding since its launch in 2020. Founded by Recursion, Altitude Lab supports diverse ...
Recursion Pharmaceuticals, Inc. operates as a clinical ... 2 clinical trial to treat AXIN1 or APC mutant cancers. Shares of RXRX traded up $1.23 during trading hours on Friday, hitting $9.73.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback